Main Article Content
miscarriage, molar pregnancy, Hydatidiform, placenta, ultrasound
Background: Molar pregnancy is a very uncommon condition in pregnancy that is characterized by abnormal trophoblast growth. It is also called the hydatidiform mole (HM). HMs are a type of gestational trophoblastic disease. There are two types of hydatidiform moles which are partial hydatidiform moles (PHM) and complete hydatidiform moles (CHM). They can both be differentiated by their genetics and biology. The progression rate to gestational trophoblastic neoplasia of partial hydatidiform moles is lower than that of complete hydatidiform moles. The progression rate of PHM is 5%, while the progression rate of CHM is from 15% to 20%.
Objective: The goal of the study is to increase the detection and treatment of molar pregnancy, particularly in areas with limited resources.
Study design: A cross-sectional study
Place and Duration: This study was conducted in Al Nafees Medical College and Hospital Islamabad from May 2022 to May 2023.
Methodology: All of the women included in this research were those who had a history of miscarriage. All of the participants were aged between 18 and 45 years. A pre-designed performa was used to gather data related to gestational age, parity, and age. A consultant ultrasonologist who had at least 5 years of experience had the responsibility of performing trans-abdominal ultrasound scanning.
Results: There were a total of 180 women enrolled in this research. The average age calculated was 28.7 years. The average height calculated was 1.56 meters. The average weight was 68.2 kg. There were 179 patients who did not have a molar pregnancy, while only one patient had a molar pregnancy. There was no significant relationship between family history, age, parity, previous molar pregnancy, BMI, and gestational age.
Conclusion: We concluded that the occurrence of molar pregnancy in females with miscarriage is very rare.
2. Kashanian M, Baradaran HR, Ghasemi A, Teimoori N. Evaluation of the risk factors of complete molar pregnancy. The Iranian Journal of Obstetrics, Gynecology and Infertility. 2011 Sep 23;14(4):9-14.
3. Kashanian M, Baradaran HR, Teimoori N. Risk factors for complete molar pregnancy: a study in Iran. The Journal of Reproductive Medicine. 2009 Oct 1;54(10):621-4.
4. Koirala A, Khatiwada P, Giri A, Kandel P, Regmi M, Upreti D. The demographics of molar pregnancies in BPKIHS. Kathmandu University Medical Journal. 2011;9(4):298-300.
5. Al-Talib AA. Clinical presentation and treatment outcome of molar pregnancy: Ten years experience at a Tertiary Care Hospital in Dammam, Saudi Arabia. Journal of family & community medicine. 2016 Sep;23(3):161.
6. Mirza N, Yasmin S, Nasrin R, Bushra RT, Nahar K. Clinical Analysis of Molar Pregnancy. Sch Int J Obstet Gynec. 2022;5(10):467-73.
7. Shafi S, Perveen S, Qureshi AI, Munir A, Qureshi HZ, Gul PI. Frequency of Molar Pregnancy in Abortion Cases Diagnosed by Histopathology Specimens at Nishtar Medical University Hospital, Multan Pakistan. Pakistan Journal of Medical & Health Sciences. 2022 Mar 26;16(02):305-.
8. FATIMA S, SHAIKH AG, MAHAR T, BOZDAR HU, MEMON S, KHOKHAR M. A Study of Molar Pregnancy at Low Resource Settings of Tertiary Care Hospital Sindh. Hypertension.;6:13-4.
9. Simms-Stewart D, Mcdonald G, Fletcher H, Bromfield M, Williams N, Bambury I, James K. A review of molar pregnancy at the university hospital of the West Indies over a 16-year period. Journal of Obstetrics and Gynaecology. 2013 Apr 1;33(3):298-300.
10. Rezavand N, Kamravamanesh M, Veisi F, Zangeneh M, Basiri S, Rezaei M. A survey on subsequent pregnancy outcome after molar pregnancy. Iranian Journal of Obstetrics, Gynecology and Infertility. 2013;16(54):1-6.
11. Alsibiani A. Value of histopathologic examination of uterine products after first- trimester miscarriage. Biomed Res Int. 2014;2014:99-104
12. Riadh BT, Abdellatif C, Wissal H, Leila A, Taher M, Abdelhamid K. Clinical analysis and management of gestational trophoblastic diseases: a 90 cases study. Int J Biomed Sci. 2009;5(4):321-25
13. Sebire NJ, Rees H, Paradinas F, Seckl M. The diagnostic implications of routine ultrasound examination in histologically confirmed early molar pregnancies. Ultrasound Obstet. Gynecol. 2001;18:662–5.
14. Schorge JOW, Schorge JO, Bradshaw KD, Halvorson LM, Schaffer JI, Corton MM. Williams Gynecology, McGraw-Hill, New York City, NY, USA, 2008.
15. Szulman AE, Surti U. The syndromes of hydatidiform mole, I: cytogenetic and morphologic correlations. Am J Obstet Gynecol 1978;131:665-71.
16. Fu J, Fang F, Xie L, Chen H, He F, Wu T, et al. Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia. Cochrane Database Syst Rev. 2012;11(9): CD007289
17. Schorge JO, Schaffer J, Halvorson LM, Hoffman BL, Bradshaw KD, Cunningham FG. “First trimester abortion,” in Williams Gynecology, McGraw-Hill, New York, NY, USA, 1st edition, 2008.
18. Safe abortion: technical and policy guidance for health systems, World Health Organization, Geneva, Switzerland, 2nd edition, 2012
19. Cormio G, Greco P, Di Vagno G, Loverro G, Vimercati A, Selvaggi L. Choriocarcinoma following term pregnancy by transvaginal color Doppler ultrasound. A two case report. Eur J Gynaecol Oncol 1996;17:151–3.
20. Sood M, Sangwaan K, Sherwaal V, Marwah S, Sen R. An unusual case of choriocarcinoma following live term pregnancy. Aust N Z J Obstet Gynaecol 2000;40:101–3.